How to Modify Drug Release in Paediatric Dosage Forms? Novel Technologies and Modern Approaches with Regard to Children’s Population

In the pharmaceutical technology, paediatric population still presents the greatest challenge in terms of developing flexible and appropriate drug dosage forms. As for many medicines, there is a lack of paediatric dosage forms adequate for a child’s age; it is a prevailing practice to use off label formulations. Children need balanced and personalized treatment, patient-friendly preparations, as well as therapy that facilitates dosing and thus eliminates frequent drug administration, which can be ensured by modified release (MR) forms. MR formulations are commonly used in adult therapy, while rarely available for children. The aim of this article is to elucidate how to modify drug release in paediatric oral dosage forms, discuss the already accessible technologies and to introduce novel approaches of manufacturing with regard to paediatric population.

[1]  Katarzyna Winnicka,et al.  How to assess orodispersible film quality? A review of applied methods and their modifications , 2019, Acta pharmaceutica.

[2]  Steven A. Ross,et al.  3D Printed “Starmix” Drug Loaded Dosage Forms for Paediatric Applications , 2018, Pharmaceutical Research.

[3]  N. Mondal THE ROLE OF MATRIX TABLET IN DRUG DELIVERY SYSTEM , 2018 .

[4]  Francesco Dalena,et al.  Bilayered buccal films as child-appropriate dosage form for systemic administration of propranolol. , 2017, International journal of pharmaceutics.

[5]  D. Fegley,et al.  Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients. , 2017, International journal of pharmaceutics.

[6]  R. Salehi,et al.  Novel Pentablock Copolymers as Thermosensitive Self-Assembling Micelles for Ocular Drug Delivery , 2017, Advanced pharmaceutical bulletin.

[7]  C. Tuleu,et al.  Medicines for children: flexible solid oral formulations , 2017, Bulletin of the World Health Organization.

[8]  M. Flament,et al.  Multi-Particulate Dosage Forms for Pediatric Use , 2017 .

[9]  J. Walsh,et al.  European Paediatric Formulation Initiative (EuPFI)—Formulating Ideas for Better Medicines for Children , 2017, AAPS PharmSciTech.

[10]  V. Klingmann Acceptability of Mini-Tablets in Young Children: Results from Three Prospective Cross-over Studies , 2017, AAPS PharmSciTech.

[11]  T. Egberts,et al.  Paediatric Drug Development and Formulation Design—a European Perspective , 2017, AAPS PharmSciTech.

[12]  P. Chugh,et al.  Pediatric Off-Label and Unlicensed Drug Use and Its Implications. , 2017, Current clinical pharmacology.

[13]  S. Uchida,et al.  Oral sustained-release suspension based on a lauryl sulfate salt/complex. , 2016, International journal of pharmaceutics.

[14]  B. Stojanovic,et al.  Investigation of omeprazole stability in oral suspensions for pediatric use prepared extemporaneously from omeprazole capsules , 2016 .

[15]  J. C. Visser,et al.  Personalized Medicine in Pediatrics: The Clinical Potential of Orodispersible Films , 2016, AAPS PharmSciTech.

[16]  M. Flament Extended-release dosage: recent advances and potential in pediatric medicine. , 2016, Therapeutic delivery.

[17]  D. V. van Riet-Nales,et al.  Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects , 2016, Archives of Disease in Childhood.

[18]  M. Alexander,et al.  3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Maren Preis,et al.  Perspective: Concepts of printing technologies for oral film formulations. , 2015, International journal of pharmaceutics.

[20]  Ronan Daly,et al.  Inkjet printing for pharmaceutics - A review of research and manufacturing. , 2015, International journal of pharmaceutics.

[21]  J. Breitkreutz,et al.  Acceptability of Uncoated Mini-Tablets in Neonates--A Randomized Controlled Trial. , 2015, The Journal of pediatrics.

[22]  Xiao Dong Chen,et al.  On the spray drying of uniform functional microparticles , 2015 .

[23]  D. V. van Riet-Nales,et al.  Methods of administering oral formulations and child acceptability. , 2015, International journal of pharmaceutics.

[24]  Felipe L. Lopez,et al.  Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms , 2015, Expert opinion on drug delivery.

[25]  S. Parmar,et al.  Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride , 2015, Results in pharma sciences.

[26]  M. Sznitowska,et al.  Can preschool-aged children swallow several minitablets at a time? Results from a clinical pilot study. , 2015, International journal of pharmaceutics.

[27]  Maren Preis,et al.  Orally Disintegrating Films and Mini-Tablets—Innovative Dosage Forms of Choice for Pediatric Use , 2015, AAPS PharmSciTech.

[28]  J. Marriott,et al.  Formulations for children: problems and solutions. , 2015, British journal of clinical pharmacology.

[29]  J. Craig,et al.  Clinical trials in children. , 2015, British Journal of Clinical Pharmacology.

[30]  N. Christiansen Ethanol exposure through medicines commonly used in paediatrics , 2014, Archives of Disease in Childhood: Education & Practice Edition.

[31]  L. van Dijk,et al.  Pediatric Drug Formulations: A Review of Challenges and Progress , 2014, Pediatrics.

[32]  C. Phadke,et al.  Novel oral suspensions: a review. , 2014, Current drug delivery.

[33]  S. Verma,et al.  Preparation and Evaluation of Novel In Situ Gels Containing Acyclovir for the Treatment of Oral Herpes Simplex Virus Infections , 2014, TheScientificWorldJournal.

[34]  T. Swain Clinical trials for children: Some concerns , 2014, Indian journal of pharmacology.

[35]  M. Sznitowska,et al.  Application properties of oral gels as media for administration of minitablets and pellets to paediatric patients. , 2014, International journal of pharmaceutics.

[36]  Jörg Breitkreutz,et al.  Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children. , 2013, The Journal of pediatrics.

[37]  C. Tuleu,et al.  'Formulating better medicines for children' - setting the pace for the future. , 2013, International journal of pharmaceutics.

[38]  M. Khan,et al.  A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly Oral Dosage Forms , 2013, The AAPS Journal.

[39]  Hiroyuki Maeda,et al.  Effects of spray drying process parameters on the solubility behavior and physical stability of solid dispersions prepared using a laboratory-scale spray dryer , 2013, Drug development and industrial pharmacy.

[40]  J. Ford,et al.  Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence , 2013, BMC Pediatrics.

[41]  R. Richey The manipulation of dosage forms of medications, with the aim of achieving the required dose, for administration to children , 2013 .

[42]  A. Nokhodchi,et al.  The role of oral controlled release matrix tablets in drug delivery systems. , 2012, BioImpacts : BI.

[43]  J. Breitkreutz,et al.  Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study , 2012, Archives of Disease in Childhood.

[44]  Pradeep Kumar,et al.  Oral Drug Delivery Systems Comprising Altered Geometric Configurations for Controlled Drug Delivery , 2011, International journal of molecular sciences.

[45]  J. Breitkreutz,et al.  Advances in orodispersible films for drug delivery , 2011, Expert opinion on drug delivery.

[46]  Sunil B Jaiswal,et al.  A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS). , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[47]  H. Shivakumar,et al.  Microencapsulation: A promising technique for controlled drug delivery , 2010, Research in pharmaceutical sciences.

[48]  K. Cal,et al.  Spray drying technique. I: Hardware and process parameters. , 2010, Journal of pharmaceutical sciences.

[49]  S. Bélanger,et al.  Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder. , 2009, Paediatrics & child health.

[50]  M. Nahata Safety of “inert” additives or excipients in paediatric medicines , 2009, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[51]  D. Svirskis,et al.  Chemical stability of extemporaneously compounded omeprazole formulations: a comparison of two methods of compounding. , 2009, International journal of pharmaceutical compounding.

[52]  N. Udupa,et al.  In Situ Forming Polymeric Drug Delivery Systems , 2009, Indian journal of pharmaceutical sciences.

[53]  L. Allen Dosage form design and development. , 2008, Clinical therapeutics.

[54]  M. Nahata,et al.  Extemporaneous drug formulations. , 2008, Clinical therapeutics.

[55]  J. Emami,et al.  Preparation and evaluation of a liquid sustained-release drug delivery system for theophylline using spray-drying technique , 2008 .

[56]  W. Hennink,et al.  In situ gelling hydrogels for pharmaceutical and biomedical applications. , 2008, International journal of pharmaceutics.

[57]  Reinhard Vehring,et al.  Pharmaceutical Particle Engineering via Spray Drying , 2007, Pharmaceutical Research.

[58]  S. Talegaonkar,et al.  Multiple emulsions: an overview. , 2006, Current drug delivery.

[59]  H Corns,et al.  Unlicensed and off label prescribing of drugs in general practice , 2000, Archives of disease in childhood.

[60]  K. Neville,et al.  Off-Label Use of Drugs in Children , 1999, Pediatrics.

[61]  S. Rasmussen,et al.  SABER®-Bupivacaine Reduces Postoperative Pain And Opioid Consumption Following Arthroscopic Subacromial Decompression , 2016 .

[62]  S. Muralidharan,et al.  A Review: Polymeric In-situ Gel System , 2013 .

[63]  H. Patel,et al.  In-Situ Gelling System : A Review , 2011 .

[64]  L. Breslow The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing. , 2003, Harvard journal on legislation.

[65]  I. Singh,et al.  Ion Exchange Resins : Drug Delivery and Therapeutic Applications , 2022 .